Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015297 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Cilostazol |
---|
Description | Cilostazol, also known as pletal, belongs to the class of organic compounds known as hydroquinolones. Hydroquinolones are compounds containing a hydrogenated quinoline bearing a ketone group. Cilostazol is an extremely weak basic (essentially neutral) compound (based on its pKa). Within humans, cilostazol participates in a number of enzymatic reactions. In particular, cilostazol can be converted into 4-hydroxycilostazol; which is mediated by the enzyme cytochrome P450 3A4. In addition, cilostazol can be converted into 4-cis-hydroxy cilostazol through its interaction with the enzymes cytochrome P450 2C19 and cytochrome P450 3A5. In humans, cilostazol is involved in cilostazol action pathway. A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substituted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group. |
---|
Structure | O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2 InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26) |
---|
Synonyms | Value | Source |
---|
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone | ChEBI | 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone | ChEBI | 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril | ChEBI | 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one | ChEBI | Cilostazolum | ChEBI | Pletal | Kegg | Cilostazole | HMDB |
|
---|
Chemical Formula | C20H27N5O2 |
---|
Average Molecular Weight | 369.4607 |
---|
Monoisotopic Molecular Weight | 369.216475133 |
---|
IUPAC Name | 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one |
---|
Traditional Name | cilostazol |
---|
CAS Registry Number | 73963-72-1 |
---|
SMILES | O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2 |
---|
InChI Identifier | InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26) |
---|
InChI Key | RRGUKTPIGVIEKM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hydroquinolones. Hydroquinolones are compounds containing a hydrogenated quinoline bearing a ketone group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Quinolones and derivatives |
---|
Direct Parent | Hydroquinolones |
---|
Alternative Parents | |
---|
Substituents | - Tetrahydroquinolone
- Tetrahydroquinoline
- Alkyl aryl ether
- Benzenoid
- Azole
- Heteroaromatic compound
- Tetrazole
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Ether
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 160 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.032 g/L | Not Available | LogP | 2.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Cilostazol,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 3478.0 | Semi standard non polar | 33892256 | Cilostazol,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 3295.5 | Standard non polar | 33892256 | Cilostazol,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 4513.0 | Standard polar | 33892256 | Cilostazol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 3695.2 | Semi standard non polar | 33892256 | Cilostazol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 3516.0 | Standard non polar | 33892256 | Cilostazol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C21 | 4583.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Cilostazol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fal-8947000000-2a45c02fa8163a7e214e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cilostazol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Cilostazol LC-ESI-qTof , Positive-QTOF | splash10-0fc3-2900000000-aeed8cd6efbb3b93af8e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cilostazol , positive-QTOF | splash10-00dr-1698000000-05ddf5c1a046516bae11 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cilostazol , positive-QTOF | splash10-01t9-3920000000-86a7d65313952e9a8d3f | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 10V, Positive-QTOF | splash10-00di-0129000000-f672b81f1eae1e02bf26 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 20V, Positive-QTOF | splash10-06za-7679000000-3558d68d922f50a245e5 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 40V, Positive-QTOF | splash10-001i-9600000000-a29f6d9a47bb72fd9433 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 10V, Negative-QTOF | splash10-014i-0529000000-1054f4f0e8e908b32dc8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 20V, Negative-QTOF | splash10-03di-2913000000-c486550cc7475c61e6e3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 40V, Negative-QTOF | splash10-01ox-5900000000-285688ae4185c24bab91 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 10V, Positive-QTOF | splash10-00di-0029000000-dcfc288c1d5ecab73a27 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 20V, Positive-QTOF | splash10-0089-9018000000-77173424302a7aea56fe | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 40V, Positive-QTOF | splash10-004i-0970000000-ddeea9f213a26978e589 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 10V, Negative-QTOF | splash10-014i-0109000000-55bee19f6f547c13b3b2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 20V, Negative-QTOF | splash10-014i-0109000000-ad4dbc3d4880ce468bb5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cilostazol 40V, Negative-QTOF | splash10-03di-1921000000-c6d1a1ca29c9d4653634 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|